Early into their hotly anticipated migraine launches, Amgen and Eli Lilly have picked up key coverage from Express Scripts, but Teva's Ajovy was left out in the cold.
Amazon should acquire Rite Aid to obtain state pharmacy licenses and add a regulatory-cleared infrastructure, according to one Wall Street analyst on Tuesday.